<DOC>
	<DOCNO>NCT00603993</DOCNO>
	<brief_summary>The purpose study evaluate long-term safety subcutaneous ( SC ) self-injections ( subject subject 's family member ) adalimumab adult Japanese subject Rheumatoid Arthritis open-label study .</brief_summary>
	<brief_title>Self-injection Adalimumab Adult Japanese Subjects With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Completed Week 36 Study M03651 [ NCT 00235872 ] Wish participate selfinjection study Give write informed consent Comply protocol requirement Subject develop serious adverse event time eligibility confirmation Subject develop severe infection require hospitalization IV injection antibiotic within 28 day eligibility confirmation Subject develop infection require oral administration antibiotic within 14 day eligibility confirmation The investigator considers subject inappropriate participation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Rheumatoid arthritis</keyword>
</DOC>